Amos B Smith, Iii

This inventor holds 46 USPTO granted patents and 14 published patent applications and 1 EPO patent, primarily in HIV-1 Inhibition. Top assignees: University of Pennsylvania, Dana-Farber-Cancer Institute Inc., Bryn Mawr College. Active years: 1983-2026.

USPTO Granted Patents = 46 (Patent Applications = 14)

% Patents Active = 89.1

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 4.6

ph-index = 7

Forward Citations = 144(Granted Patents)

Company Filing History:

43 out of 2,651

University of Pennsylvania

patents

3 out of 1,265

Dana-Farber-Cancer Institute Inc.

University of California

Johns Hopkins University

patents

8. 1 out of 110

Kosan Biosciences Incorporated

patents

9. 1 out of 51

Monell Chemical Senses Center

patents

10. 1 out of 224

University Patents, Inc.

patents

11. 1 out of 20

Val-Chum, Limited Partnership

patents

12. 2 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1983-2026

Loading Chart...

Areas of Expertise:

HIV-1

Antibody Dependent Cellular Cytotoxicity

Microtubule Stabilizers

Peptidomimetics

Neurodegenerative

Silicon Coupling Agents

Cycloalkyl-Dione Derivatives

Thromboxane Antagonists

Synthetic Techniques

Pyrrolinones

Dicarbonyl Compounds

Alpha-Aminophosphonates

46 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12729194 - Compounds for the treatment of human immunodeficiency virus (2026-09-08),

2. 12286401 - Small molecules that sensitize HIV-1 infected cells to antibody dependent cellular cytotoxicity (2025-04-29),

3. 11623927 - Substituted [1,2,4]triazolo[1,5-a]pyrimidines for stabilizing microtubules (2023-04-11),

4. 9975848 - Inhibitors of HIV-1 entry and methods of use thereof (2018-05-22),

5. 9850469 - Methods of stapling and unstapling peptides and proteins (2017-12-26),

6. 9850261 - Silicon-based cross coupling agents and methods of their use (2017-12-26),

7. 9776963 - Small molecule CD4 mimetics and uses thereof (2017-10-03),

8. 9649317 - Heterocyclic compounds and their use for the treatment of neurodegenerative tauopathies (2017-05-16),

9. 9643919 - Cycloalkyl-dione derivatives and methods of their use (2017-05-09),

10. 9540355 - Irciniastatin analogues (2017-01-10),

11. 9499660 - Silicon-based cross coupling agents and methods of their use (2016-11-22),

12. 9403763 - CD4-mimetic inhibitors of HIV-1 entry and methods of use thereof (2016-08-02),

13. 8957097 - Hemi-phorboxazole A derivatives and methods of their use (2015-02-17),

14. 8927586 - Thromboxane A2 (TP) receptor antagonists (2015-01-06),

15. 8586632 - Use of the irritating principal oleocanthal in olive oil, as well as structurally and functionally similar compounds (2013-11-19),

Title: Inventor Amos B Smith, III

Introduction: Amos B Smith, III is a renowned inventor based in Merion, Pennsylvania. He has made significant contributions to the field of innovation through his groundbreaking work in various patents.

Latest Patents: Amos B Smith, III holds several recent patents in the areas of chemical engineering and pharmaceuticals, showcasing his ongoing commitment to advancing technology and science.

Career Highlights: With a distinguished career spanning several decades, Amos B Smith, III has established himself as a leading figure in the world of inventors. His innovative solutions have revolutionized the industry and earned him widespread recognition.

Collaborations: Throughout his career, Amos B Smith, III has collaborated with top research institutions, universities, and companies to bring his inventions to life. His partnerships have been instrumental in the success of many groundbreaking projects.

Conclusion: In conclusion, Amos B Smith, III's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor in Merion, PA, and beyond.